ICCC
#3987
ImmuCell Corporation - Common Stock
10.0 0 USD
0.00%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-0.20%
Variación mensual
-10.71%
Variación en los últimos 6 meses
+49.48%
Cambio anual
+58.98%
Cierres anteriores
10.0 2
Open
10.3 0
Mínimo
10.0 0
Máximo
10.3 0
Volumen
4
Financials
- Market Capitalization 90.82 M
- Employee 73
- Founded 1982
- CEO Michael F Brigham
- Website www.immucell.com
- Headquarter Delaware, United States
- FIGI BBG000BLQ5Q2
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-51.25
Relación precio/flujo de caja
2.01
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3980 |  ATRA Atara Biotherapeutics, Inc. - Common Stock | 9.03 USD | -2.38% | -5.15% | +16.67% | -38.78% | 90.64 M USD | ||
| 3983 |  ALDX Aldeyra Therapeutics, Inc. - Common Stock | 1.51 USD | -1.95% | -1.95% | -4.43% | -74.23% | 91.09 M USD | ||
| 3997 |  ACRV Acrivon Therapeutics, Inc. - Common Stock | 2.07 USD | -3.72% | -5.91% | +38.00% | +55.64% | 88.71 M USD | ||
| 3999 |  VRCA Verrica Pharmaceuticals Inc. - Common Stock | 5.31 USD | +4.73% | +11.79% | -0.75% | -11.79% | 91.22 M USD |